ALLO stock · SWK stock

ALLO vs SWK · rev $4.6M vs P/E 34, rev $7.81B

Allogene Therapeutics Inc (ALLO) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.

Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.

Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.

Latest reported ALLO revenue for 2026-06-30 was $4.6M. Net income was -$85.3M. ALLO currently screens at market cap $258.1M.

Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.

ALLO currently screens at market cap $258.1M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.

Not investment advice. Open the ALLO and SWK stock pages for the full models.

Not investment advice.

Popular Stock Comparisons